315 related articles for article (PubMed ID: 12891543)
1. Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine.
Savidge TC; Pan WH; Newman P; O'brien M; Anton PM; Pothoulakis C
Gastroenterology; 2003 Aug; 125(2):413-20. PubMed ID: 12891543
[TBL] [Abstract][Full Text] [Related]
2. Epithelial cell I kappa B-kinase beta has an important protective role in Clostridium difficile toxin A-induced mucosal injury.
Chae S; Eckmann L; Miyamoto Y; Pothoulakis C; Karin M; Kagnoff MF
J Immunol; 2006 Jul; 177(2):1214-20. PubMed ID: 16818780
[TBL] [Abstract][Full Text] [Related]
3. Clostridium difficile toxins A and B can alter epithelial permeability and promote bacterial paracellular migration through HT-29 enterocytes.
Feltis BA; Wiesner SM; Kim AS; Erlandsen SL; Lyerly DL; Wilkins TD; Wells CL
Shock; 2000 Dec; 14(6):629-34. PubMed ID: 11131913
[TBL] [Abstract][Full Text] [Related]
4. Theodore E. Woodward Award. How bacterial enterotoxins work: insights from in vivo studies.
Lamont JT
Trans Am Clin Climatol Assoc; 2002; 113():167-80; discussion 180-1. PubMed ID: 12053708
[TBL] [Abstract][Full Text] [Related]
5. Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa.
Castagliuolo I; Riegler MF; Valenick L; LaMont JT; Pothoulakis C
Infect Immun; 1999 Jan; 67(1):302-7. PubMed ID: 9864230
[TBL] [Abstract][Full Text] [Related]
6. IL-8 release and neutrophil activation by Clostridium difficile toxin-exposed human monocytes.
Linevsky JK; Pothoulakis C; Keates S; Warny M; Keates AC; Lamont JT; Kelly CP
Am J Physiol; 1997 Dec; 273(6):G1333-40. PubMed ID: 9435559
[TBL] [Abstract][Full Text] [Related]
7. Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro.
Lima AA; Lyerly DM; Wilkins TD; Innes DJ; Guerrant RL
Infect Immun; 1988 Mar; 56(3):582-8. PubMed ID: 3343050
[TBL] [Abstract][Full Text] [Related]
8. The American Cockroach Peptide Periplanetasin-2 Blocks
Hong J; Zhang P; Yoon IN; Hwang JS; Kang JK; Kim H
J Microbiol Biotechnol; 2017 Apr; 27(4):694-700. PubMed ID: 28173695
[No Abstract] [Full Text] [Related]
9. Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.
Koon HW; Ho S; Hing TC; Cheng M; Chen X; Ichikawa Y; Kelly CP; Pothoulakis C
Antimicrob Agents Chemother; 2014 Aug; 58(8):4642-50. PubMed ID: 24890583
[TBL] [Abstract][Full Text] [Related]
10. Toxigenic C. difficile induced inflammatory marker expression by human intestinal epithelial cells is asymmetrical.
Canny G; Drudy D; Macmathuna P; O'farrelly C; Baird AW
Life Sci; 2006 Jan; 78(9):920-5. PubMed ID: 16185718
[TBL] [Abstract][Full Text] [Related]
11. Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis.
Castagliuolo I; Riegler M; Pasha A; Nikulasson S; Lu B; Gerard C; Gerard NP; Pothoulakis C
J Clin Invest; 1998 Apr; 101(8):1547-50. PubMed ID: 9541482
[TBL] [Abstract][Full Text] [Related]
12. Clostridium Difficile, Colitis, and Colonoscopy: Pediatric Perspective.
McConnie R; Kastl A
Curr Gastroenterol Rep; 2017 Aug; 19(8):34. PubMed ID: 28707191
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].
Deniz U; Ulger N; Aksu B; Karavuş M; Söyletir G
Mikrobiyol Bul; 2011 Jan; 45(1):1-10. PubMed ID: 21341153
[TBL] [Abstract][Full Text] [Related]
14. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.
Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS
World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020
[TBL] [Abstract][Full Text] [Related]
15. Effects of Clostridium difficile toxins on epithelial cell barrier.
Pothoulakis C
Ann N Y Acad Sci; 2000; 915():347-56. PubMed ID: 11193598
[TBL] [Abstract][Full Text] [Related]
16. Clostridium difficile-derived membrane vesicles induce the expression of pro-inflammatory cytokine genes and cytotoxicity in colonic epithelial cells in vitro.
Nicholas A; Jeon H; Selasi GN; Na SH; Kwon HI; Kim YJ; Choi CW; Kim SI; Lee JC
Microb Pathog; 2017 Jun; 107():6-11. PubMed ID: 28284851
[TBL] [Abstract][Full Text] [Related]
17. Effect of antisera from Clostridium difficile-infected mice on toxin-A-induced colonic epithelial cell death signaling.
Kim DH; Lee IH; Nam ST; Nam HJ; Kang JK; Seok H; Hwang JS; Kim H
J Microbiol Biotechnol; 2014 May; 24(5):696-703. PubMed ID: 24509250
[TBL] [Abstract][Full Text] [Related]
18. Toxicity assessment of Clostridium difficile toxins in rodent models and protection of vaccination.
Wang S; Rustandi RR; Lancaster C; Hong LG; Thiriot DS; Xie J; Secore S; Kristopeit A; Wang SC; Heinrichs JH
Vaccine; 2016 Mar; 34(10):1319-23. PubMed ID: 26614590
[TBL] [Abstract][Full Text] [Related]
19. Repetitive domain of Clostridium difficile toxin B exhibits cytotoxic effects on human intestinal epithelial cells and decreases epithelial barrier function.
Zemljic M; Rupnik M; Scarpa M; Anderluh G; Palù G; Castagliuolo I
Anaerobe; 2010 Oct; 16(5):527-32. PubMed ID: 20620216
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro.
Riegler M; Sedivy R; Pothoulakis C; Hamilton G; Zacherl J; Bischof G; Cosentini E; Feil W; Schiessel R; LaMont JT
J Clin Invest; 1995 May; 95(5):2004-11. PubMed ID: 7738167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
